Literature DB >> 20686847

Over-expression of Ephb4 is associated with carcinogenesis of gastric cancer.

M Li1, Z W Zhao, Y Zhang, Y Xin.   

Abstract

BACKGROUND: Gastric cancer is one of the most frequently diagnosed malignancies in the world. The gene expression profile and molecular grouping of gastric cancer has been a challenging task due to its inherent complexity and variation among individuals. AIMS: To determine the molecular mechanism associated with gastric carcinogenesis.
METHODS: We analyzed the gene expression profiles of 20 cancerous tissues and their tumor-adjacent tissue from patients with gastric cancer by using a 14 K cDNA microarray. The differentially expressed genes and their products were verified by semiquantitative reverse transcription PCR (RT-PCR), western blotting and immunohistochemistry of gastric cancer and normal tissue samples.
RESULTS: A total of 69 genes were found to be differentially regulated in the cancerous tissue. Among them, genes such as CDH17, ETV4, S100A6, S100A11, Ephb4, and KLK10 were confirmed by RT-PCR to be up-regulated, while genes such as NK4 and PPP2R1B were down-regulated. Western blotting and immunohistochemistry indicated that Ephb4 was over-expressed and localized to the cytoplasm of gastric cancer cells. Moreover, Ephb4 protein was observed as being significantly related to tumor size and pN category (p = 0.001 and 0.007, respectively).
CONCLUSIONS: These newly identified genes might provide a valuable resource for understanding the molecular mechanism associated with the carcinogenesis of gastric cancer and for finding potential diagnostic markers of gastric cancer.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20686847     DOI: 10.1007/s10620-010-1346-7

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  25 in total

1.  THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA. AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION.

Authors:  P LAUREN
Journal:  Acta Pathol Microbiol Scand       Date:  1965

2.  Gene expression profiling of gastric cancer by microarray combined with laser capture microdissection.

Authors:  Ming-Shiang Wu; Yi-Shing Lin; Yu-Ting Chang; Chia-Tung Shun; Ming-Tsan Lin; Jaw-Town Lin
Journal:  World J Gastroenterol       Date:  2005-12-21       Impact factor: 5.742

3.  Ca2+-binding protein S100A11: a novel diagnostic marker for breast carcinoma.

Authors:  Xiang-Guo Liu; Xiao-Ping Wang; Wan-Feng Li; Shuo Yang; Xin Zhou; Si-Jie Li; Xiang-Jun Li; Dong-Yun Hao; Zhi-Min Fan
Journal:  Oncol Rep       Date:  2010-05       Impact factor: 3.906

4.  Frizzled-7 receptor ectodomain expression in a colon cancer cell line induces morphological change and attenuates tumor growth.

Authors:  Elizabeth Vincan; Phillip K Darcy; Mark J Smyth; Erik W Thompson; Robert J S Thomas; Wayne A Phillips; Robert G Ramsay
Journal:  Differentiation       Date:  2005-04       Impact factor: 3.880

5.  EphB4 expression and biological significance in prostate cancer.

Authors:  Guangbin Xia; S Ram Kumar; Rizwan Masood; Sutao Zhu; Ramchandra Reddy; Valery Krasnoperov; David I Quinn; Susan M Henshall; Robert L Sutherland; Jacek K Pinski; Siamak Daneshmand; Maurizio Buscarini; John P Stein; Chen Zhong; Daniel Broek; Pradip Roy-Burman; Parkash S Gill
Journal:  Cancer Res       Date:  2005-06-01       Impact factor: 12.701

6.  Alterations in the suppressor gene PPP2R1B in parathyroid hyperplasias and adenomas.

Authors:  Samuli Hemmer; Veli Matti Wasenius; Caj Haglund; Ying Zhu; Sakari Knuutila; Kaarle Franssila; Heikki Joensuu
Journal:  Cancer Genet Cytogenet       Date:  2002-04-01

7.  The prognostic impact of EphB2/B4 expression on patients with advanced ovarian carcinoma.

Authors:  Qinghua Wu; Zhenhe Suo; Gunnar B Kristensen; Mark Baekelandt; Jahn M Nesland
Journal:  Gynecol Oncol       Date:  2006-02-23       Impact factor: 5.482

8.  [Evaluation and problems of follow-up surveillance after curative gastric cancer surgery].

Authors:  Atsushi Nashimoto; Hiroshi Yabusaki; Satoru Nakagawa
Journal:  Nihon Geka Gakkai Zasshi       Date:  2007-05

9.  Interplay between EphB4 on tumor cells and vascular ephrin-B2 regulates tumor growth.

Authors:  Nicole K Noren; Mark Lu; Andrew L Freeman; Mitchell Koolpe; Elena B Pasquale
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-05       Impact factor: 11.205

10.  EPHB4 gene polymorphisms and risk of intracranial hemorrhage in patients with brain arteriovenous malformations.

Authors:  Shantel Weinsheimer; Helen Kim; Ludmila Pawlikowska; Yongmei Chen; Michael T Lawton; Stephen Sidney; Pui-Yan Kwok; Charles E McCulloch; William L Young
Journal:  Circ Cardiovasc Genet       Date:  2009-08-22
View more
  10 in total

1.  Antral atrophy, intestinal metaplasia, and preneoplastic markers in Mexican children with Helicobacter pylori-positive and Helicobacter pylori-negative gastritis.

Authors:  Rodolfo Villarreal-Calderon; Arturo Luévano-González; Mariana Aragón-Flores; Hongtu Zhu; Ying Yuan; Qun Xiang; Benjamin Yan; Kathryn Anne Stoll; Janet V Cross; Kenneth A Iczkowski; Alexander Craig Mackinnon
Journal:  Ann Diagn Pathol       Date:  2014-02-11       Impact factor: 2.090

2.  KSR1 and EPHB4 Regulate Myc and PGC1β To Promote Survival of Human Colon Tumors.

Authors:  Jamie L McCall; Drew Gehring; Beth K Clymer; Kurt W Fisher; Binita Das; David L Kelly; Hyunseok Kim; Michael A White; Robert E Lewis
Journal:  Mol Cell Biol       Date:  2016-08-12       Impact factor: 4.272

3.  Clinical Significance of EphB4 and EphB6 Expression in Human Malignant and Benign Thyroid Lesions.

Authors:  Constantinos Giaginis; Paraskevi Alexandrou; Elpida Poulaki; Ioanna Delladetsima; Constantinos Troungos; Efstratios Patsouris; Stamatios Theocharis
Journal:  Pathol Oncol Res       Date:  2015-07-30       Impact factor: 3.201

4.  PEA3 transcription factors are downstream effectors of Met signaling involved in migration and invasiveness of Met-addicted tumor cells.

Authors:  Zoulika Kherrouche; Didier Monte; Elisabeth Werkmeister; Luc Stoven; Yvan De Launoit; Alexis B Cortot; David Tulasne; Anne Chotteau-Lelievre
Journal:  Mol Oncol       Date:  2015-07-15       Impact factor: 6.603

5.  The kallikrein-related peptidase 13 (KLK13) gene is substantially up-regulated after exposure of gastric cancer cells to antineoplastic agents.

Authors:  Dimitra Florou; Konstantinos Mavridis; Andreas Scorilas
Journal:  Tumour Biol       Date:  2012-09-05

6.  Urinary kallikrein 10 predicts the incurability of gastric cancer.

Authors:  Takaya Shimura; Masahide Ebi; Tomonori Yamada; Tamaki Yamada; Takahito Katano; Yu Nojiri; Hiroyasu Iwasaki; Satoshi Nomura; Noriyuki Hayashi; Yoshinori Mori; Hiromi Kataoka; Marsha A Moses; Takashi Joh
Journal:  Oncotarget       Date:  2017-04-25

7.  Overexpression of erythropoietin-producing hepatocyte receptor B4 and ephrin-B2 is associated with estrogen receptor expression in endometrial adenocarcinoma.

Authors:  Ling-Dan Dong; Xiang-Lin Cheng; Long Zhou; Qing Huang; Jun-Chuan Li; Cun-Jian Yi
Journal:  Oncol Lett       Date:  2017-02-08       Impact factor: 2.967

Review 8.  Lipid Metabolism in Cancer: The Role of Acylglycerolphosphate Acyltransferases (AGPATs).

Authors:  Angeliki Karagiota; Georgia Chachami; Efrosyni Paraskeva
Journal:  Cancers (Basel)       Date:  2022-01-04       Impact factor: 6.639

9.  Epstein-barr virus infected gastric adenocarcinoma expresses latent and lytic viral transcripts and has a distinct human gene expression profile.

Authors:  Weihua Tang; Douglas R Morgan; Michael O Meyers; Ricardo L Dominguez; Enrique Martinez; Kennichi Kakudo; Pei Fen Kuan; Natalie Banet; Hind Muallem; Kimberly Woodward; Olga Speck; Margaret L Gulley
Journal:  Infect Agent Cancer       Date:  2012-08-28       Impact factor: 2.965

10.  Long noncoding RNA BC005927 upregulates EPHB4 and promotes gastric cancer metastasis under hypoxia.

Authors:  Xiangqiang Liu; Yafang Wang; Li Sun; Jie Min; Jiaming Liu; Di Chen; Hongbo Zhang; Hongwei Zhang; Helong Zhang; Yongan Zhou; Lili Liu
Journal:  Cancer Sci       Date:  2018-03-05       Impact factor: 6.716

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.